CG Oncology, Inc. (CGON)
(Real Time Quote from BATS)
$25.41 USD
-1.53 (-5.68%)
Updated Aug 6, 2025 03:16 PM ET
5-Strong Sell of 5 5
F Value F Growth B Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, CG Oncology, Inc. has a market cap of $2.05B, which represents its share price of $26.94 multiplied by its outstanding shares number of 76.22M. As a mid-cap company, CGON's shareholders are generally exposed to less risk than shareholders of small-cap companies but more risk than large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
CGON 25.41 -1.53(-5.68%)
Will CGON be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for CGON based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CGON
Arbutus Biopharma (ABUS) Beats Q2 Earnings and Revenue Estimates
CGON Stock Rallies 27% in a Month on Bladder Cancer Study Success
CGON: What are Zacks experts saying now?
Zacks Private Portfolio Services
Company News for May 14, 2025
CG Oncology, Inc. (CGON) Reports Q1 Loss, Lags Revenue Estimates
Y-mAbs Therapeutics, Inc. (YMAB) Reports Q1 Loss, Tops Revenue Estimates
Other News for CGON
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
September 19th Options Now Available For CG Oncology (CGON)
CGON's Price Target Lowered by RBC Capital, Rating Maintained | CGON Stock News
RBC Capital Adjusts Price Target for CG Oncology (CGON) Amid Positive Outlook | CGON Stock News